S 5719119th CongressIn Committee
Genomic Answers for Children’s Health Act of 2026
Standard Summary
Balanced plain-English summary
This bill would clarify that Medicaid covers whole genome and whole exome sequencing for children suspected of having genetic disorders, rare diseases, or conditions of unknown origin, including certain congenital anomalies and developmental delays. It also requires separate payment, outreach and education, and government reports on access and outcomes.
Key Points
- 1Amends Medicaid to cover whole genome and whole exome sequencing as first-tier tests for certain children
- 2Requires separate payment rather than bundling with other medical assistance
- 3Directs HHS outreach and a public report on payment amounts and outcomes
- 4Requires GAO analysis of access barriers and recommendations
Impact Areas
Children with rare or genetic conditionsMedicaid beneficiaries and familiesStates and Medicaid managed care organizationsGenetic testing laboratories and providersHHS and GAO
Generated by deepseek/deepseek-v4.1-flash-1017Nov 19, 2026